| Product Code: ETC10765654 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Portugal`s pemetrexed import market in 2024 continues to see a diverse range of suppliers, with top countries like Germany, Spain, and Belgium leading the way. The market remains competitive with low concentration, providing opportunities for various exporters. The compound annual growth rate (CAGR) from 2020 to 2024 is stable at 2.5%, while the growth rate from 2023 to 2024 stands at 2.21%. This indicates a steady and sustainable growth trajectory for pemetrexed imports in Portugal, with a stable market landscape and potential for further expansion.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Pemetrexed Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Pemetrexed Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Pemetrexed Market - Industry Life Cycle |
3.4 Portugal Pemetrexed Market - Porter's Five Forces |
3.5 Portugal Pemetrexed Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Portugal Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 Portugal Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2021 & 2031F |
3.8 Portugal Pemetrexed Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Portugal Pemetrexed Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
4 Portugal Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Portugal Pemetrexed Market Trends |
6 Portugal Pemetrexed Market, By Types |
6.1 Portugal Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Portugal Pemetrexed Market Revenues & Volume, By Indication, 2021 - 2031F |
6.1.3 Portugal Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021 - 2031F |
6.1.4 Portugal Pemetrexed Market Revenues & Volume, By Mesothelioma, 2021 - 2031F |
6.1.5 Portugal Pemetrexed Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.1.6 Portugal Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.1.7 Portugal Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2021 - 2031F |
6.2 Portugal Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Portugal Pemetrexed Market Revenues & Volume, By Antifolate, 2021 - 2031F |
6.2.3 Portugal Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2021 - 2031F |
6.2.4 Portugal Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2021 - 2031F |
6.2.5 Portugal Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2021 - 2031F |
6.2.6 Portugal Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2021 - 2031F |
6.3 Portugal Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Portugal Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2021 - 2031F |
6.3.3 Portugal Pemetrexed Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.3.4 Portugal Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.3.5 Portugal Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.3.6 Portugal Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.4 Portugal Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Portugal Pemetrexed Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Portugal Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.4.4 Portugal Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.5 Portugal Pemetrexed Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Portugal Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.5 Portugal Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Portugal Pemetrexed Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.3 Portugal Pemetrexed Market Revenues & Volume, By Injection, 2021 - 2031F |
6.5.4 Portugal Pemetrexed Market Revenues & Volume, By IV Infusion, 2021 - 2031F |
6.5.5 Portugal Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.5.6 Portugal Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2021 - 2031F |
7 Portugal Pemetrexed Market Import-Export Trade Statistics |
7.1 Portugal Pemetrexed Market Export to Major Countries |
7.2 Portugal Pemetrexed Market Imports from Major Countries |
8 Portugal Pemetrexed Market Key Performance Indicators |
9 Portugal Pemetrexed Market - Opportunity Assessment |
9.1 Portugal Pemetrexed Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Portugal Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 Portugal Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2021 & 2031F |
9.4 Portugal Pemetrexed Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Portugal Pemetrexed Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
10 Portugal Pemetrexed Market - Competitive Landscape |
10.1 Portugal Pemetrexed Market Revenue Share, By Companies, 2024 |
10.2 Portugal Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here